Protecting our value through IP
AMADIX recognizes the importance of developing IP strategies early to determine how it could serve our long-term business interests. We capture the value of our innovation through strong patent protection.
Our Products
PreveCol®
PreveCol® is an innovative blood-based test for the early detection of colorectal cancer (CRC) or advanced adenomas (AA) and precancerous lesions. Based on an algorithm that combines clinical characteristics with an analysis of biomarkers present in the individual’s blood.
CE Marked
DiagnoLung®
DiagnoLung® is an innovative blood-based test for the early detection of lung cancer. Non-invasive test that can be used for the diagnosis of lung cancer and as a screening tool in high-risk populations.
Under development
PancreaDix®
PancreaDix® is an innovative blood-based test for the detection of pancreatic cancer (ductal adenocarcinoma and preneoplastic lesions). Non-invasive test.
Under development
